Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1972-7-29
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0001-6101
pubmed:author
pubmed:issnType
Print
pubmed:volume
190
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
455-63
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:5149274-Adolescent, pubmed-meshheading:5149274-Adult, pubmed-meshheading:5149274-Age Factors, pubmed-meshheading:5149274-Blood Group Antigens, pubmed-meshheading:5149274-Contraceptives, Oral, pubmed-meshheading:5149274-Denmark, pubmed-meshheading:5149274-Ethinyl Estradiol, pubmed-meshheading:5149274-Female, pubmed-meshheading:5149274-Fibrinolysis, pubmed-meshheading:5149274-Great Britain, pubmed-meshheading:5149274-Humans, pubmed-meshheading:5149274-Lynestrenol, pubmed-meshheading:5149274-Male, pubmed-meshheading:5149274-Mestranol, pubmed-meshheading:5149274-Myocardial Infarction, pubmed-meshheading:5149274-Norethindrone, pubmed-meshheading:5149274-Sweden, pubmed-meshheading:5149274-Thromboembolism, pubmed-meshheading:5149274-Thrombophlebitis, pubmed-meshheading:5149274-Thrombosis, pubmed-meshheading:5149274-Time Factors, pubmed-meshheading:5149274-United States
pubmed:year
1971
pubmed:articleTitle
Oral contraceptives and thromboembolic disease. Swedish experience.
pubmed:publicationType
Journal Article